Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
about
Membrane binding and bending in Ebola VP40 assembly and egressOutbreaks of Ebola virus disease in Africa: the beginnings of a tragic sagaEbola virus diseaseDevelopment of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusEbola Hemorrhagic Fever as a Public Health Emergency of International Concern; a Review ArticleFiloviruses: One of These Things is (not) Like the OtherAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksPre-symptomatic diagnosis and treatment of filovirus diseasesNeglected filovirusesClomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic ImplicationsMolecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine TriphosphateImmucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral LeishmaniasisA Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola VirusBroad-spectrum agents for flaviviral infections: dengue, Zika and beyondUpdates in diagnosis and management of Ebola hemorrhagic fever.Ebola virus: A gap in drug design and discovery - experimental and computational perspective.Ebola virus - from neglected threat to global emergency state.Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infectionPotential clinical treatment for Ebola pandemic.Flavonoids as multi-target inhibitors for proteins associated with Ebola virus: in-silico discovery using virtual screening and molecular docking studies.The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies.Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model.THE STRENGTHS, WEAKNESSES, OPPORTUNITIES, AND THREATS (SWOTs) ANALYSES OF THE EBOLA VIRUS - PAPER RETRACTED.Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Possible leap ahead in filovirus therapeutics.High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona.BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster modelSynthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challengeTreatment of ebola virus disease.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Small molecules with antiviral activity against the Ebola virusTherapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.A Randomized, Controlled Trial of ZMapp for Ebola Virus InfectionStructures of protective antibodies reveal sites of vulnerability on Ebola virus.Humanitarian access to unapproved interventions in public health emergencies of international concern.Mechanism of human antibody-mediated neutralization of Marburg virusHigh-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses.
P2860
Q21131091-0F527C5C-1FD6-4D31-AC0A-AD8B4FF732ECQ21245402-FF99984C-1588-40F1-B674-3C6C72A050E4Q24563097-C37C1F6F-CEFF-4833-B7B5-B72B23A16586Q26700054-335122AC-8265-4A5F-87C1-DCFB3CB28BA3Q26778083-70ED5F5E-1BEE-4CF3-AC4F-526C55FD087AQ26783063-5F35C782-A823-472B-9204-F0ED75F09DEFQ26801423-6FE2F8F1-45F4-468E-A611-234C2C2BC2D5Q26823831-2AB18EAF-E97D-4F4F-B6FF-AA402B8D5DC8Q28383265-7D24DFB0-3F7E-469A-B1D5-98349383DAA7Q28387522-A87E5FE2-8F9D-41C7-ACEA-7C4B6F6BE593Q28548547-5AD6669A-540B-4D43-847D-0E551511649AQ28551736-B5113C77-422E-4566-AE98-30E5E3D1CCA7Q28552295-8B492F66-2EF2-4F01-9FCD-E3B132BF722AQ29994527-30C9776D-D6E3-49E1-BB51-16CF15419490Q30238537-0929440F-0A95-4424-8E1F-963FE708A1E2Q30243938-38317C30-C753-43DB-B53A-70DF356804B1Q30245153-8A8F53B1-8C99-431D-8531-CE6DBBBD8DEAQ30251949-789A103B-5EC6-43E3-8929-80ACEE2A6415Q30252022-5EFFB3B1-C6A7-4F90-8D12-CE7F05D3136BQ30252649-3F6149E0-ABBC-4706-9489-0D08787EEC23Q30366997-1F6CD39E-8D07-4BE2-A5BA-C86A7F43457FQ30371564-1353C0DD-F987-4A94-901E-BBA54C696824Q30376138-C78D1BFF-58F8-4B17-910D-2F80158225A4Q30378093-E176326F-47F2-4D7A-BC65-C81A459E0D52Q30395163-BB561C5E-08FD-4380-96C6-1F44072B5652Q30401753-D7D1F27C-8AFE-4499-B95F-08D086B37DEEQ33439713-BB621490-521F-4B28-B43C-074E70DFA9C2Q33701830-7787FF01-4AB8-4370-97E0-3AFD91E62FA4Q33919019-2E50428C-82FD-4035-AB0B-20DC4D190559Q34041804-832EEEDC-DEAB-483A-848E-7A7F5BF42021Q34361120-1540A95C-E820-4F32-9030-BFB149EB8A2CQ34460182-D1FEB1AF-D005-4A17-92C1-BCBD07AA53FBQ34463780-558A8A0F-A606-42BF-822F-3412D785892CQ34464403-A5548607-75CB-463E-A1AA-87F61E7345B7Q34516555-30B97FAA-0653-40C9-9506-61B059A1310DQ34542427-A86B18A0-FD06-4E0A-A4F7-05E97A8035A9Q34661120-423F3392-D681-47AF-8DDC-D5BA50594836Q35119707-05127CBA-E904-4D5E-AED0-00B72CAB8381Q35132756-E2A8F39D-F70B-4263-971A-027F984DFEC4Q35363438-EEFB00F8-F1AF-402C-858B-335222394467
P2860
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@ast
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@en
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@nl
type
label
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@ast
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@en
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@nl
prefLabel
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@ast
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@en
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@nl
P2093
P2860
P50
P356
P1433
P1476
Protection against filovirus d ...... m nucleoside analogue BCX4430.
@en
P2093
Brett P Eaton
Brian R Taubenheim
Cary J Retterer
Dena M Minning
Kelly S Stuthman
Lisa S Welch
Nicole L Garza
Pravin Kotian
P2860
P2888
P304
P356
10.1038/NATURE13027
P407
P577
2014-03-02T00:00:00Z
P6179
1027597733